"""
TRAIN/VALIDATION/TEST SPLIT CLARIFICATION
==========================================

Based on the training code analysis:
"""

print("=" * 70)
print("TRAIN/VALIDATION/TEST SPLIT STRATEGY")
print("=" * 70)

print("\nACTUAL IMPLEMENTATION:")
print("-" * 70)
print("Split Configuration:")
print("  - Training Set:   80% (4,693 slices from 'train' folder)")
print("  - Validation Set: 20% (1,140 slices from 'test' folder)")
print("  - Test Set:       SAME AS VALIDATION (1,140 slices)")
print()
print("Code Evidence:")
print("  train_dataset = LungMultiClassDataset(DATA_ROOT, split='train')")
print("  val_dataset   = LungMultiClassDataset(DATA_ROOT, split='test')")
print()
print("What This Means:")
print("  - NO separate validation split during training")
print("  - The 'test' folder is used as validation during training")
print("  - Model selection based on performance on 'test' set")
print("  - Final evaluation also done on the same 'test' set")

print("\n" + "=" * 70)
print("DETAILED BREAKDOWN")
print("=" * 70)

print("\nTraining Phase:")
print("  - Data: 4,693 slices (80.5%)")
print("  - Patients: 148")
print("  - Used for: Model weight updates")

print("\nValidation Phase (During Training):")
print("  - Data: 1,140 slices (19.5%)")
print("  - Patients: 147")
print("  - Used for: Model selection, early stopping, LR scheduling")
print("  - Evaluated every epoch")

print("\nTest Phase (Final Evaluation):")
print("  - Data: SAME 1,140 slices")
print("  - Patients: SAME 147")
print("  - Used for: Final performance reporting")

print("\n" + "=" * 70)
print("IMPORTANT NOTE FOR IEEE PAPER")
print("=" * 70)

print("\n⚠️  CRITICAL ISSUE:")
print("  The validation and test sets are IDENTICAL.")
print("  This means:")
print("  - Model was selected based on test set performance")
print("  - Risk of overfitting to test set through hyperparameter tuning")
print("  - Not ideal for rigorous evaluation")

print("\nHOW TO REPORT IN PAPER:")
print("-" * 70)

print("\nOption 1 (Honest - Recommended):")
print('  "We employed an 80/20 train-test split (4,693 training slices,')
print('   1,140 test slices). Model selection and hyperparameter tuning')
print('   were performed using the test set, with the best model selected')
print('   based on validation Dice score. While this approach lacks a')
print('   separate validation set, early stopping (patience=10) was used')
print('   to prevent overfitting."')

print("\nOption 2 (Standard Terminology):")
print('  "We split the dataset into 80% training (4,693 slices) and 20%')
print('   validation (1,140 slices). The model was trained for up to 120')
print('   epochs with early stopping based on validation Dice score.')
print('   Final performance was evaluated on the validation set."')
print('  Note: Call it "validation" instead of "test" to avoid confusion')

print("\nOption 3 (If You Can Re-train):")
print("  Proper split would be:")
print("    - Training:   70% (3,285 slices)")
print("    - Validation: 10% (468 slices)")
print("    - Test:       20% (1,170 slices)")
print("  This requires re-training with proper data split")

print("\n" + "=" * 70)
print("RECOMMENDATION")
print("=" * 70)

print("\nFor IEEE Paper Submission:")
print("  1. Be transparent about the split strategy")
print("  2. Use 'validation set' terminology (not 'test set')")
print("  3. Acknowledge limitation in discussion section")
print("  4. Emphasize early stopping as regularization")
print("  5. Mention patient-level split (no data leakage)")

print("\nSample Text:")
print("-" * 70)
print('"The dataset was divided into training (80%, 4,693 slices from')
print(' 148 patients) and validation (20%, 1,140 slices from 147 patients)')
print(' sets. Model selection was performed based on validation set')
print(' performance, with early stopping (patience=10 epochs) to prevent')
print(' overfitting. The best model achieved a mean Dice score of 92.57%')
print(' on the validation set."')

print("\n" + "=" * 70)
